{"title":"Smith+Nephew vs Zimmer Biomet: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/smith-nephew-vs-zimmer-biomet","comparison":"Zimmer Biomet ranks 60 on the Robotics 100 with a score of 81; Smith+Nephew ranks 65 with 81. The eight measures are level. Smith+Nephew is based in Watford, United Kingdom, Zimmer Biomet in Warsaw, United States. Smith+Nephew: Established. Zimmer Biomet: Public. Smith+Nephew is named in 2 signals and Zimmer Biomet in 11.","companies":[{"name":"Smith+Nephew","url":"https://www.frontiertechintelligence.com/companies/smith-nephew","city":"Watford","country":"United Kingdom","stage":"Established","founded":null,"last_round":null,"positioning":"Smith+Nephew's CORI handheld robotic platform (within the LSE:SN group) covers revision knee, hip, and shoulder procedures in hospital and ASC settings, with CORI XT first clinical cases in June 2026 (shoulder arthroplasty at Duke Health, knee at NYU Langone). It showcased handheld robotics at AAOS 2026. CORI-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":65,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Smith+Nephew develops and sells the CORI Surgical System, a robotic-assisted platform for orthopedic surgery. Its medical robotics business qualifies as a medical and surgical robotics system.","segment":"Medical & surgical","layer":"Systems"},"signals_total":2,"facts_total":10},{"name":"Zimmer Biomet","url":"https://www.frontiertechintelligence.com/companies/zimmer-biomet","city":"Warsaw","country":"United States","stage":"Public","founded":null,"last_round":null,"positioning":"Zimmer Biomet is a US orthopedics company (NYSE:ZBH) whose ROSA robotic platform serves knee, hip, and shoulder procedures, now adding the Monogram semi-autonomous TKA system (FDA 510(k) in March 2025, an early-2027 launch) with a fully autonomous version in clinical study since July 2025. It completed the Monogram Technologies acquisition in October 2025. ROSA-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":60,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Zimmer Biomet develops and sells ROSA robotic surgical systems for orthopedic procedures, including robotic assistance and navigation for knee, hip, and brain surgery.","segment":"Medical & surgical","layer":"Systems"},"signals_total":11,"facts_total":4}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}